Bioteknisk forskning och utveckling SNI 72101
I branschen Bioteknisk forskning och utveckling finns 353 aktiebolag med årsredovisningsdata. Störst är Procella Therapeutics AB med en omsättning på 115.0 M kr.
353
aktiebolag
542.8 M
kr i samlad omsättning
562
anställda
-3.6%
median rörelsemarginal
Största bolagen 2026 — efter omsättning, senaste bokslut
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 1 | Procella Therapeutics AB | 115.0 M | -20.4 M | -17.7% | 45 |
| 2 | Cellcolabs AB | 44.2 M | -97.3 M | -202.6% | 68 |
| 3 | TATAA BIOCENTER AB | 40.4 M | -43.0 M | -106.4% | 33 |
| 4 | QAdvis AB | 38.5 M | 112.8 k | 0.3% | 23 |
| 5 | Xpress Genomics AB | 25.4 M | 11.5 M | 45.2% | 5 |
| 6 | Sweden Medtech4Health AB (svb) | 23.1 M | -1.3 k | -0.0% | 3 |
| 7 | Pharmability AB | 21.6 M | -2.9 M | -13.5% | 1 |
| 8 | Atley Solutions AB | 17.9 M | -11.6 M | -41.7% | 13 |
| 9 | IONLACE AB | 14.7 M | -3.8 M | -26.0% | 9 |
| 10 | Raaven Therapeutics AB | 13.7 M | 2.9 M | 20.9% | 6 |
| 11 | Smartwise Sweden AB | 10.5 M | -9.0 M | -18.5% | 6 |
| 12 | NBAB, Nordic BioAnalysis AB | 10.4 M | 225.4 k | 2.2% | 7 |
| 13 | Scandinavian Physix AB | 9.1 M | 1.2 M | 13.2% | 3 |
| 14 | BIOFUEL REGION BFR AB | 8.4 M | -207.8 k | -2.4% | 8 |
| 15 | THE PACKAGING GREENHOUSE AB | 8.1 M | 1.1 M | 13.0% | 3 |
| 16 | Bifrost Biosystems AB | 6.8 M | -4.3 M | -62.2% | 3 |
| 17 | Salipro Biotech AB | 6.6 M | -5.1 M | -75.1% | 7 |
| 18 | Beactica Therapeutics AB | 5.7 M | -7.3 M | -127.9% | 5 |
| 19 | Nordberg Medical AB | 5.6 M | 859.4 k | 15.4% | — |
| 20 | AmbioGen AB | 4.8 M | 1.7 M | 35.7% | 4 |
| 21 | Moligo Technologies AB | 4.7 M | -1.5 M | -12.7% | 4 |
| 22 | FreSun AB | 3.9 M | 2.6 M | 67.2% | 1 |
| 23 | Bench2Bedside AB | 3.5 M | 1.3 M | 35.7% | 1 |
| 24 | AI Biotech Sverige AB | 3.3 M | 809.0 k | 24.3% | 2 |
| 25 | Key2Brain AB | 3.3 M | -396.1 k | -8.4% | 3 |
| 26 | K&S Services AB | 3.2 M | 507.6 k | 14.8% | 6 |
| 27 | K.Sandvold Consulting AB | 3.1 M | 1.7 M | 56.3% | 1 |
| 28 | LePeMo Consulting AB | 2.9 M | 1.7 M | 58.6% | 1 |
| 29 | Oxion Biologics AB | 2.9 M | -20.4 M | -144.9% | 3 |
| 30 | Wlness Science Sweden AB | 2.6 M | 15.6 k | 0.6% | 3 |
| 31 | ANYO Labs AB | 2.4 M | -1.9 M | -38.5% | 9 |
| 32 | Circio AB | 2.4 M | -22.2 M | -830.1% | 5 |
| 33 | Ebba Biotech AB | 2.2 M | -1.3 M | -55.9% | 3 |
| 34 | MS Lab Tech Consulting AB | 2.2 M | -3.0 k | -0.1% | 2 |
| 35 | Innoext AB | 1.9 M | -509.0 k | -27.0% | 2 |
| 36 | Cloud Gravity AB | 1.8 M | 660.3 k | 37.4% | 1 |
| 37 | IVRS AB | 1.6 M | 614.4 k | 17.9% | 2 |
| 38 | Compliant Consulting AB | 1.5 M | 487.1 k | 31.6% | 1 |
| 39 | GENTEC SOLUTIONS AB | 1.5 M | 771.0 k | 50.2% | — |
| 40 | HER CONSULTING AB | 1.5 M | 522.9 k | 34.1% | 1 |
| 41 | Korsbo Computing AB | 1.5 M | 382.0 k | 25.8% | 1 |
| 42 | ArtSci AB | 1.5 M | 1.4 M | 97.0% | — |
| 43 | Zyli medical consulting AB | 1.4 M | 660.1 k | 46.4% | 1 |
| 44 | Treat4Life AB | 1.4 M | 243.7 k | 17.3% | 1 |
| 45 | Lithea AB | 1.4 M | -8.6 M | -521.2% | 4 |
| 46 | Rarity Bioscience AB | 1.4 M | -20.2 M | -814.7% | 16 |
| 47 | Moroxite Holding AB | 1.3 M | 474.2 k | 35.9% | 0 |
| 48 | Vesiclebio AB | 1.3 M | 11.0 k | 0.8% | 1 |
| 49 | Pampas Nordic Group AB | 1.2 M | -31.9 k | -2.7% | — |
| 50 | Celluxtreme AB | 1.1 M | 233.5 k | 5.2% | 5 |
| 51 | SELA Consulting AB | 1.1 M | 397.6 k | 37.4% | — |
| 52 | Nygen Analytics AB | 1.1 M | -2.3 M | -85.3% | — |
| 53 | Redutt AB | 1.0 M | 157.6 k | 15.4% | — |
| 54 | Probarix AB | 1.0 M | 363.4 k | 33.5% | — |
| 55 | RB Morbus Medical AB | 1.0 M | 310.5 k | 30.9% | 1 |
| 56 | Cebi Family AB | 937.3 k | -226.7 k | -24.2% | 1 |
| 57 | Kuprin Consulting AB | 913.7 k | 86.5 k | 9.3% | 2 |
| 58 | Indevex AB | 903.0 k | -5.6 M | -624.3% | — |
| 59 | SCNexa AB | 890.2 k | 599.5 k | 67.3% | 1 |
| 60 | MSunds Research Consulting Services AB | 886.4 k | 233.9 k | 26.2% | 1 |
| 61 | AABIO AB | 873.9 k | 799.9 k | 91.5% | — |
| 62 | Aktiebolaget SUND sound medical decision | 872.0 k | 37.2 k | 4.3% | 1 |
| 63 | Biotech Isendahl AB | 864.2 k | 42.9 k | 5.0% | 1 |
| 64 | Axel Ståhlbom Biologics Regulatory Advice AB | 860.4 k | -8.6 k | -1.0% | 1 |
| 65 | Semple Scientific AB | 842.9 k | 639.9 k | 75.9% | — |
| 66 | Oakshire Medicine AB | 841.1 k | 485.1 k | 57.7% | 1 |
| 67 | Selenozyme AB | 829.8 k | -19.7 k | -2.2% | 0 |
| 68 | ImmCon AB | 816.2 k | 801.1 k | 98.1% | 0 |
| 69 | Gyllensten Science Consulting AB | 810.0 k | 615.0 k | 75.9% | — |
| 70 | Anath Genomic Consultants AB | 784.5 k | 2.9 k | 0.4% | 1 |
| 71 | Fulgurite AB | 782.4 k | -167.5 k | -21.4% | 1 |
| 72 | FREDRIK BUCH KONSULT AKTIEBOLAG | 779.6 k | -195.0 k | -25.0% | 1 |
| 73 | BioResM AB | 779.4 k | 93.2 k | 12.0% | 1 |
| 74 | ToxoTech AB | 737.6 k | -820.2 k | -111.2% | 1 |
| 75 | Sculptur Sweden AB | 728.9 k | -478.7 k | -50.3% | 1 |
| 76 | Sens-EI consulting AB | 709.1 k | 426.2 k | 59.8% | 1 |
| 77 | JG Bioinformatics AB | 698.1 k | 374.3 k | 53.6% | 1 |
| 78 | Fredriksson BioConsulting AB | 698.1 k | 93.2 k | 13.3% | — |
| 79 | BioFysiologisk Analys Sverige AB | 694.2 k | 12.2 k | 1.8% | — |
| 80 | BIOREGA AB | 659.6 k | 152.4 k | 23.1% | 1 |
| 81 | Living Implants AB | 645.8 k | 57.8 k | 9.0% | 1 |
| 82 | Währborg Research & Consulting AB | 576.9 k | 364.2 k | 63.0% | — |
| 83 | Stealth Labels Biotech AB | 556.3 k | -230.6 k | -12.2% | 3 |
| 84 | Kaul&Raina AB | 532.1 k | 318.3 k | 59.8% | 1 |
| 85 | Medili AB | 530.0 k | 100 | 0.0% | — |
| 86 | Bioremedi AB | 523.8 k | -51.5 k | -9.8% | 0 |
| 87 | Leffler Bild och Bildning AB | 488.7 k | 11.9 k | 2.4% | 1 |
| 88 | Ranrike Vetenskap AB | 484.8 k | 476.7 k | 89.1% | — |
| 89 | Bactaviva AB | 483.5 k | -225.2 k | -46.6% | 0 |
| 90 | DEAB Dala Energiutveckling AB | 468.1 k | 71.4 k | 15.3% | 2 |
| 91 | David Wiggins AB | 461.8 k | -303.2 k | -65.7% | 1 |
| 92 | SPLATomics AB | 432.4 k | 181.2 k | 41.9% | — |
| 93 | Medirista Biotechnologies AB | 430.0 k | 343.5 k | 79.9% | — |
| 94 | Binfe AB | 426.0 k | 183.6 k | 43.1% | 1 |
| 95 | GATomics AB | 413.3 k | -65.0 k | -15.6% | 0 |
| 96 | Biotome AB | 399.8 k | 22.1 k | 5.5% | — |
| 97 | ProteomEdge AB | 390.6 k | -6.6 M | -1661.5% | 3 |
| 98 | Dalén Research AB | 385.4 k | 255.3 k | 66.2% | — |
| 99 | Westin Noxa-health AB | 351.1 k | 181.1 k | 51.6% | 0 |
| 100 | Galinos AB | 342.9 k | 265.7 k | 77.5% | 1 |
1–100 av 353 bolag · sida 1 av 4